Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Day One Biopharmaceuticals

Request full access

Cancer drug development comes of age. Follow

San Francisco, United StatesFounded 2018Biotech & Life Sciences

About Day One Biopharmaceuticals

Day One Biopharmaceuticals focuses on developing innovative treatments for pediatric cancer through a collaborative approach involving multiple stakeholders. The company operates in the biopharmaceutical industry, targeting unmet medical needs in pediatric oncology. Its business model revolves around drug development, clinical trials, and partnerships with healthcare providers and research institutions. Revenue is generated through the commercialization of successful drug candidates and strategic alliances. Day One Biopharmaceuticals serves patients, healthcare providers, and research communities, aiming to improve outcomes for children with cancer.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2021
Employees
252
Open positions
2
Dealroom signal
88.4/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Oncology, Verified Unicorns and $1B Exits, Post IPO $1B, Biotech and Pharma, DT and LS, science-based
Client focus
B2B
Investment activity
1 company, latest Nov 2025
Capital deployed
—
Preferred round
ACQUISITION

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Mar 2026 $2.5B $2.5B Servier ↗
PRIVATE PLACEMENT VCOther financing Jul 2024 $175M — Wellington Management · Deerfield · Fairmount Funds Management · Frazier Life Sciences ↗
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Day One Biopharmaceuticals website traffic

Latest recorded traffic for Day One Biopharmaceuticals is 6.9K monthly website visits, down 46.9% over the last three months. Day One Biopharmaceuticals's team grew 14.5% over the past year.

Latest monthly visits6.9K 3-month web change-46.9% 1-year team growth+14.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Day One Biopharmaceuticals in the San Francisco ecosystem

Live from Dealroom

The Day One Biopharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

17 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A11 investors entered at this stage

Other known investors6 additional known investors

Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States98.9%
🇨🇭 Switzerland0.5%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Day One Biopharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Day One Biopharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.